Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05957406 · ClinicalTrials.gov registry record · NA
SMART TRENDS Study
A NA study, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- NA
- Development phase
- 296
- Enrollment target
NCT05957406 is a NA study that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 296 participants.
The verdict
NCT05957406, a NA study, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 296 participants
- Enrollment target
Study Summary
A multicenter, interventional, feasibility comparison with historical controls
Interventions
- DEVICE Acumen HPI Smart Alerts and Smart Trends Software
- DEVICE The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2025-10-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05957406
The ClinicalTrials.gov registry entry for NCT05957406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 296 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acumen HPI Smart Alerts and Smart Trends Software is the first listed.
NCT05957406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05957406 about?
NCT05957406 is a clinical study titled "SMART TRENDS Study". A multicenter, interventional, feasibility comparison with historical controls
What is the current status of trial NCT05957406?
This trial is currently completed. It is a NA study. The enrollment target is 296 participants. The study started on 2023-07-11. Estimated completion is 2025-10-27.
What interventions are being tested in trial NCT05957406?
The interventions under investigation include: Acumen HPI Smart Alerts and Smart Trends Software (DEVICE), The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff (DEVICE).
Who is sponsoring clinical trial NCT05957406?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.